AACR Annual Meeting 2023: Demystifying Immune Ecosystems
As the spring weather encourages the planting of flowers, vegetables, and herbs, even careful gardeners may see weeds creeping...
As the spring weather encourages the planting of flowers, vegetables, and herbs, even careful gardeners may see weeds creeping...
Early detection is key to improving outcomes from cancer. Shifting the focus even earlier in the natural history of...
The AACR Annual Meeting 2023 set a new record this year with the number of clinical trial abstracts submitted...
Earlier this month, over 21,000 researchers, clinicians, patients, and other stakeholders gathered at the AACR Annual Meeting 2023 to...
Historically, most cancer drugs have been tested separately in adults and children. For the approval of new drugs for...
“Are you ready to have a great meeting?” Robert Vonderheide, MD, DPhil, asked the nearly 11,000 attendees gathered in...
People of African descent who receive genetic testing have fewer actionable mutations compared with white people—suggesting fewer available treatment...
New study finds drug combination after surgery helps prevent recurrence in liver cancer patients.
The 2015 approval of an immune checkpoint inhibitor for renal cell carcinoma (RCC) provided a much-needed new treatment option...
Accumulating research shows lifelong stressors degrade health and increase cancer risk, but exercise might help counteract the impact of...